Profile and investment
| Fund type | Open Ended Investment Company |
|---|---|
| Investment style (stocks) | Market Cap: Large Investment Style: Blend |
| Morningstar category | Large Blend |
| Launch date | 01 Nov 2004 |
| Price currency | USD |
| Domicile | United States |
| Symbol | POSKX |
| Manager & start date | Theo Kolokotrones 01 Nov 2004 Joel Fried 01 Nov 2004 Alfred Mordecai 01 Nov 2004 M. Ansari 12 Apr 2012 James Marchetti 01 Nov 2014 |
| Pricing frequency | Daily |
|---|---|
| Total net assets | 6.04bn USD As of Mar 31 2024 |
| Share class size | 6.04bn USD As of Mar 31 2024 |
| Net expense ratio | 0.67% |
| Front end load | -- |
| Deferred load | -- |
| Maximum Redemption Fee | -- |
| Min. initial investment | 2,000.00 USD |
| Min. additional investment | 100.00 USD |
| Initial IRA | 1,000.00 USD |
| Additional IRA | 100.00 USD |
| Available for sale | United States |
More ▼
Top 5 holdings
| Top 5 holdings as a per cent of portfolio | |||
|---|---|---|---|
| 49.54% | 24.30% | 0.00% | 24.30% |
| Category average | % Net assets | % Short | % Long |
| Company | 1 year change | Portfolio weight | Long allocation |
|---|---|---|---|
| Eli Lilly and Co LLY:NYQ | +87.78% | 10.37% | |
| AstraZeneca PLC 0A4J:LSE | +3.67% | 3.66% | |
| Dreyfus Treasury Secs Cash Mgmt Inst | 0.00% | 3.61% | |
| AECOM ACM:NYQ | +12.45% | 3.35% | |
| KLA Corp KLAC:NSQ | +78.42% | 3.31% | |
| Per cent of portfolio in top 5 holdings: 24.30% |
Asset type
| US stock | 81.55% |
| Non-US stock | 15.17% |
| Cash | 3.28% |
| US bond | 0.00% |
| Non-US bond | 0.00% |
| Other | 0.00% |
Top 5 sectors
| Healthcare | 26.90% |
| Technology | 24.91% |
| Industrials | 19.09% |
| Financial Services | 9.67% |
| Consumer Cyclical | 6.79% |
| Other | 9.37% |
Top 5 regions
| United States | 81.55% |
| United Kingdom | 4.33% |
| Eurozone | 3.74% |
| Latin America | 2.51% |
| Japan | 2.24% |
| Other | 2.35% |
Sector and region weightings are calculated using only long position holdings of the portfolio.
